Endospan
Jerusalem, Israel· Est.
Endospan delivers innovative, custom‑made aortic arch stent grafts to enable minimally invasive repair of complex thoracic aortic disease.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Endospan delivers innovative, custom‑made aortic arch stent grafts to enable minimally invasive repair of complex thoracic aortic disease.
CardiovascularVascular Surgery
Technology Platform
The NEXUS platform comprises custom‑made, multi‑branch aortic arch stent grafts that provide enhanced durability, intra‑procedural stability, and minimally invasive delivery for complex thoracic aortic pathology.
Opportunities
Regulatory clearance in the U.S.
and Europe could unlock a multi‑billion‑dollar market for endovascular aortic arch repair, especially for patients unsuitable for open surgery.
Risk Factors
Dependence on successful FDA approval, manufacturing scale‑up, and reimbursement adoption pose significant execution risks.
Competitive Landscape
Endospan competes with traditional EVAR/TEVAR manufacturers and emerging custom‑graft firms; its multi‑branch design and custom‑made approach provide a distinct advantage in complex arch anatomy.